Skip to main content

Table 3 Number of IL-17 and IFN-γ spot-forming cells (median and range)

From: Th17-skewed immune response and cluster of differentiation 40 ligand expression in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis

Groups

 

IL-17

IFN-γ

SRMA A (n = 18)

Median

12.83

43.83

Range

(3.33–34.67)

(1.67–315.00)

SRMA T (n = 9)

Median

13.00

25.33

Range

(1.00–95.33)

(5.33–169.67)

Healthy (n = 16)

Median

4.34

291.50

Range

(0.67–14.00)

(77.67–695.00)

Idiopathic epilepsy (n = 10)

Median

28.33

109.17

Range

(2.33–66.00)

(35.33–350.00)

MUO (n = 8)

Median

13.50

87.50

Range

(3.33–74.67)

(20.33–296.67)

IVDH (n = 7)

Median

7.67

61.00

Range

(5.67–44.67)

(12.00–215.33)

Miscellaneous (n = 8)

Median

6.84

42.50

Range

(1.67–33.00)

(14.00–369.00)

  1. SFCs spot-forming cells, IL-17 interleukin-17, IFN-γ Interferon gamma, SRMA A steroid-responsive meningitis-arteritis in acute stage, SRMA T SRMA patients under treatment, MUO meningoencephalitis of unknown origin, IVDH intervertebral disc herniation